stockrowMadrigal Pharmaceuticals, Inc. (MDGL) vs Bio-Techne Corp (TECH)
- Madrigal Pharmaceuticals, Inc. MDGL 397.03 −0.77%
- Bio-Techne Corp TECH 72.79 +0.18%
Madrigal Pharmaceuticals, Inc. and Bio-Techne Corp are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $9.3B — 1.2× the size. Madrigal Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 66.2×. Madrigal Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 92.8% against 0.94%. Bio-Techne Corp has the higher net margin (14.0% vs −10.9%) and the higher return on invested capital (8.29% vs −1,480.3%). Across the 18 metrics below, Bio-Techne Corp leads on 13 and Madrigal Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | MDGL | TECH | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.96% | 65.75% | 68.51% |
| Operating margin | (10.69%) | 19.61% | 0.00% |
| Net margin | (10.89%) | 14.00% | 0.00% |
| Free cash flow margin | (11.81%) | 25.09% | 0.00% |
| Return on equity | (24.82%) | 8.32% | (51.96%) |
| Return on assets | (11.12%) | 6.66% | (46.06%) |
| Return on invested capital | (1,480.32%) | 8.29% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack